PSCs Reveal PUFA-Provoked Mitochondrial Stress as a Central Node Potentiating RPE Degeneration in Bietti’s Crystalline Dystrophy
Zhao Zhang,Bin Yan,Fei Gao,Qing Li,Xiaohong Meng,Peikai Chen,Lei Zhou,Wen Deng,Cheng Li,Weiyi Xu,Shuo Han,Hong Feng,Yaping Li,Junhui Chen,Zhengqin Yin,Can Liao,Hung-Fat Tse,Aimin Xu,Qizhou Lian
DOI: https://doi.org/10.1016/j.ymthe.2020.07.024
IF: 12.91
2020-12-01
Molecular Therapy
Abstract:<p>Bietti's crystalline retinal dystrophy (BCD) is an incurable disorder caused by <em>CYP4V2</em> mutations. Patients with BCD present degeneration of retinal pigmented epithelial cells (RPE) and consequent blindness. The lack of appropriate disease models and patients' RPE cells limits our understanding on the pathological mechanism of RPE degeneration. In this study, using <em>CYP4V2</em> mutant pluripotent stem cells as disease models, we demonstrated that RPE cells with <em>CYP4V2</em> mutations presented a disrupted fatty acid homeostasis, which were characterized with excessive accumulation of poly-unsaturated fatty acid (PUFA) including arachidonic acid (AA) and eicosapentaenoic acid (EPA). The PUFA-overload increased mitochondrial <em>reactive oxygen species,</em> impaired mitochondrial respiratory functions, and triggered mitochondrial stress-activated p53-independent apoptosis in <em>CYP4V2</em> mutant RPE cells. Restoration of the mutant <em>CYP4V2</em> using adeno-associated virus 2 (AAV2) can effectively reduce PUFA deposition, alleviate mitochondria oxidative stresses, and rescue RPE cell death in BCD RPE cells. Together, our results highlight a role of PUFA-induced mitochondrial damage as a central node to potentiate the RPE degeneration in BCD patients. The AAV2-mediated gene therapy may represent a feasible strategy for the treatment of BCD.</p>
genetics & heredity,medicine, research & experimental,biotechnology & applied microbiology